Indication intelligence, analysis and sector perception

RegMed Investors’ (RMi) pre-open: black Friday

November 29, 2019 9:05am

Investors continued to watch for developments on U.S.-China trade following a recent escalation in tensions over Hong Kong

Pre-open indications: Like yesterday, clean the table and bag the remainders

It’s an honor to be considered the “canary in the (sectors) coal mine”! I post about “indication intelligence” devoting my time to collection and analysis of information to assist investors in the perception of sector vulnerabilities and strengths – it’s more than opinion, the facts and truth need to be recognized!

Who is feeding your portfolio “intel” - profit from RMi’s analysis!

Dow futures are DOWN -0.17% (-48 points), S&P futures are DOWN -0.17% (-5 points) and NASDAQ futures are DOWN -0.25% (+22 points)

U.S. stock index futures were lower ahead of a shortened trading session;

European markets traded lower as the pan-European Stoxx 600 fell 0.4% in early deals;

Asia Pacific stocks were lower on Friday, with stocks in Hong Kong leading losses among major markets in the region;

Data Docket: there’s will be a focus on the retail sector due to Black Friday sales. It is a question of consumer spending …

Henry’omics:

We have been riding a fast horse of four up sessions from last Friday – I’ve maintained that sustainability has a lot riding on it and I’m calling for profit taking.

Sentiment has been diminished by a recent escalation in tensions between Washington and Beijing after U.S. President Donald Trump signed legislation in support of the Hong Kong protesters. China’s foreign ministry responded, claiming the U.S. had “sinister intentions.”

Thursday was a holiday and markets were closed, Wednesday night’s newsletter heading: “the sector notched its fourth straight day of gains. Tax loss selling should not be an issue this year, says some – I disagree, it’s about portfolio management.”

Wednesday the IBB closed up +0.91% and the XBI closed up +1.39% following Tuesday’s IBB closing up +0.23% while the XBI closed up +0.14% and last Monday’s close of the IBB upside of +2.84% while the XBI also closed up +3.75%;
Wednesday the close was positive with an A/D line of 26/13, 3 flat, 1 reversed merged (HSGX) and 2 acquired; after Tuesday’s close was positive with an A/D line of 23/19, 0 flat, 1 reversed merged (HSGX) and 2 acquired following Monday’s positive close with an A/D line of 34/8, 0 flat, 1 reversed merged (HSGX) and 2 acquired;
The range of the 26 upside was +0.31% (BOLD) to +7.62% (MDXG) while the 13 downside ranged from -0.07% (QURE) to -1.96% (XON);
8 out of the 26 upside had higher than the 3 month average volume;
8 out of the 13 downside had higher than the 3 month average volume;

Review the context of Q4’s market – so far:

November has registered 1 holiday, 11 positive and 8 negative close;
October registered 10 positive, 1 neutral and 14 negative closes;

Companies in my headlights – It’s your decision; I provide an idea and context:

Pre-open indications: Pre-open indications: Like yesterday, clean the table and bag the remainders

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.